Inside Precision Medicine September 25, 2024
Providing a detailed summary of the year in cancer research, the fourteenth edition of the annual American Association of Cancer Research (AACR) Cancer Progress Report to Congress and the American public was released last week. The key finding is that cancer rates continue to climb, but death rates are shrinking. However, progress has not been even against all cancer types or all stages of a given cancer type.
But it was a banner year (July 1, 2023, through June 30, 2024), with 15 new anticancer therapeutics approved for use by the FDA. During the same period, FDA also approved a new imaging agent to aid breast cancer surgery and expanded the use of 15 previously approved anticancer therapeutics to treat...
Today's Sponsors
Today's Sponsor